A comparative study of the effectivity of MSC-based, NP-based and combined therapies in an experimental model of NaIO3-induced retinal degeneration
Katerina Palacka, Barbora Hermankova, Tereza Cervena, Pavel Rossner, Vladimir Holan, Eliska Javorkova

TL;DR
This study compares the effectiveness of MSCs, nanoparticles, and their combination in treating retinal degeneration, finding that combined therapy reduces immunomodulatory effects.
Contribution
The study reveals that combining MSCs with AgNPs decreases their immunomodulatory effects in retinal degeneration models.
Findings
MSCs or AgNPs alone modulate inflammation in retinal degeneration.
Combined MSCs and AgNPs reduce the immunomodulatory effects of each therapy.
MSCs increase expression of retinal markers and growth factors like IGF-1 and GDNF.
Abstract
Mesenchymal stem cells (MSCs) represent the promising options for retinal therapy and combined therapy with nanoparticles (NPs) could currently provide increased immunoregulatory and neuroprotective effects. Therefore, we tested the effect of silver (Ag)NPs on the properties of MSCs in an experimental model of chronic retinal degeneration. The results showed that simultaneous administration had no effect on the survival of MSCs, but a less effective local regulation of Iba-1 expression compared to MSC- or AgNP-only treated groups was observed. In addition, MSCs applied alone or in combination with AgNPs and sorted from the degenerated retina had increased expression of genes for retinal markers (rhodopsin, S-antigen, recoverin), and for TGF-β and IGF-1. These effects were confirmed also on protein level by increased production of IGF-1 and proportion of rhodopsin+ MSCs. Nevertheless,…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsRetinal Development and Disorders · Corneal Surgery and Treatments · Advanced Nanomaterials in Catalysis
